Terms: = Head and neck cancer AND MYOD1, ENSG00000129152, 4654, P15172, PUM, MYOD, MYF3 AND Clinical Outcome
3 results:
1. Genomic Classification and clinical outcome in Rhabdomyosarcoma: A Report From an International Consortium.
Shern JF; Selfe J; Izquierdo E; Patidar R; Chou HC; Song YK; Yohe ME; Sindiri S; Wei J; Wen X; Rudzinski ER; Barkauskas DA; Lo T; Hall D; Linardic CM; Hughes D; Jamal S; Jenney M; Chisholm J; Brown R; Jones K; Hicks B; Angelini P; George S; Chesler L; Hubank M; Kelsey A; Gatz SA; Skapek SX; Hawkins DS; Shipley JM; Khan J
J Clin Oncol; 2021 Sep; 39(26):2859-2871. PubMed ID: 34166060
[TBL] [Abstract] [Full Text] [Related]
2. Combined Sclerosing and Spindle Cell Rhabdomyosarcoma in Previous Craniotomy Site: A Case Report and a Review of the Literature.
Gui H; Lhospital E; Staddon AP; Nagda SN; Zager EL; Zhang PJL; Brooks JS
Int J Surg Pathol; 2019 May; 27(3):328-335. PubMed ID: 30270691
[TBL] [Abstract] [Full Text] [Related]
3. [Clinicopathologic features of pleomorphic rhabdomyosarcoma].
Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):147-52. PubMed ID: 23769431
[TBL] [Abstract] [Full Text] [Related]
